Beijing Tiantan Biological Products Co., Ltd.
Status: Publicly traded
Direct answer
Beijing Tiantan Biological Products Co., Ltd. is publicly traded on SHH under the ticker 600161.SS.
Beijing Tiantan Biological Products Co., Ltd., established in 1998 and headquartered in Beijing, China, is actively involved in the full spectrum of blood product operations within China. This includes pioneering research and development, manufacturing, sales, and providing consultancy services. Its comprehensive product line features critical blood-derived medicines such as intravenous immunoglobulin, human...
Can you invest in Beijing Tiantan Biological Products Co., Ltd.?
Yes. Beijing Tiantan Biological Products Co., Ltd. is publicly traded on SHH under the ticker 600161.SS.
View deeper analysis
View detailed research on MarketSnap, including financials, valuation tools, and analyst context.
Open research for Beijing Tiantan Biological Products Co., Ltd.
Detailed equity research is provided by MarketSnap.